We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Trade Desk
TTD
$6.81B
| $5.91M | 0.01% |
60,491
+58,465
| +2,886% | +$5.27M |
|
677
Kite Realty
KRG
$5.14B
| $5.89M | 0.01% |
263,042
+350
| +0.1% | +$7.46K |
|
678
Coursera
COUR
$1.39B
| $5.87M | 0.01% |
819,969
+160,881
| +24% | +$1.53M |
|
679
Portland General Electric
POR
$5.63B
| $5.86M | 0.01% |
135,460
+2,575
| +2% | +$111K |
|
680
Alibaba
BABA
$267B
| $5.85M | 0.01% |
81,257
-1,159,900
| -93% | -$88.9M |
|
681
Old National Bancorp
ONB
$9.68B
| $5.81M | 0.01% |
337,981
+2,158
| +0.6% | +$35.9K |
|
|
RVNC
682
DELISTED
Revance Therapeutics, Inc.
RVNC
| $5.75M | 0.01% |
2,237,505
+672,803
| +43% | +$2.3M |
|
683
Old Dominion Freight Line
ODFL
$36.2B
| $5.73M | 0.01% |
32,420
-90,100
| -74% | -$17M |
|
684
CRH
CRH
$57.7B
| $5.71M | 0.01% |
76,087
+2,500
| +3% | +$199K |
|
685
Lamb Weston
LW
$6.53B
| $5.66M | 0.01% |
67,359
-76,794
| -53% | -$6.55M |
|
686
Mistras Group
MG
$617M
| $5.65M | 0.01% |
682,106
| – | – |
|
|
VERV
687
DELISTED
Verve Therapeutics
VERV
| $5.62M | 0.01% |
1,151,550
-2,405,027
| -68% | -$15.1M |
|
688
Alkami Technology
ALKT
$2.03B
| $5.62M | 0.01% |
197,264
+34
| +0% | +$878 |
|
|
EWCZ
689
DELISTED
European Wax Center
EWCZ
| $5.61M | 0.01% |
565,000
-795,000
| -58% | -$9.03M |
|
690
Griffon
GFF
$4.22B
| $5.6M | 0.01% |
87,675
+2,403
| +3% | +$163K |
|
691
Flex
FLEX
$39.9B
| $5.57M | 0.01% |
188,818
| – | – |
|
|
VRNT
692
DELISTED
Verint Systems
VRNT
| $5.56M | 0.01% |
172,525
-17,241
| -9% | -$549K |
|
693
Unisys
UIS
$179M
| $5.51M | 0.01% |
1,334,155
+162,177
| +14% | +$794K |
|
694
Molson Coors Class B
TAP
$7.29B
| $5.47M | 0.01% |
107,692
+5,822
| +6% | +$337K |
|
695
Reliance Steel & Aluminium
RS
$20.1B
| $5.46M | 0.01% |
19,111
-192
| -1% | -$57.8K |
|
696
Zillow
ZG
$7.2B
| $5.45M | 0.01% |
121,064
-7,530
| -6% | -$325K |
|
697
Westlake Corp
WLK
$9.03B
| $5.42M | 0.01% |
37,397
-58,654
| -61% | -$9.01M |
|
698
OFG Bancorp
OFG
$2.22B
| $5.38M | 0.01% |
143,740
+67
| +0% | +$2.44K |
|
699
Shutterstock
SSTK
$183M
| $5.37M | 0.01% |
138,719
+67,718
| +95% | +$2.75M |
|
|
CIVI
700
DELISTED
Civitas Resources
CIVI
| $5.36M | 0.01% |
77,726
-13,223
| -15% | -$957K |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.